http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101756541-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-20 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N27-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N1-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-92 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N27-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N1-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
filingDate | 2015-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2017-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2017-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101756541-B1 |
titleOfInvention | Method for diagnosing a diabetic skin disease using the concentration of skin lipid metabolites and screening thereby |
abstract | The present invention relates to a method for measuring the concentration of ceramide in skin lipids obtained from a subject, And comparing the concentration of the measured ceramide with the concentration of ceramide in the skin lipids obtained from the normal group to determine whether or not the disease is a diabetic skin disease, and a method for providing information for diagnosis or treatment of diabetic skin disease will be. In addition, by using the above-mentioned principle as a marker for diabetic skin disease, the lipid metabolite in the skin lipid obtained from the subject can be effectively used as a marker for diabetes or diabetic skin disease It can also be used to judge. |
priorityDate | 2015-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 184.